title: Syst-Eur--a multicenter trial on the treatment of isolated systolic hypertension in the elderly: first interim report.
abstract: Syst-Eur is a multicenter placebo-controlled outcome trial designed by the European Working Party on High Blood Pressure in the Elderly to investigate the effect of antihypertensive treatment on the incidence of stroke in elderly patients with isolated systolic hypertension (ISH). Eligible patients must be at least 60 years old and have a systolic blood pressure averaging 160-219 mm Hg with a diastolic blood pressure less than 95 mm Hg. The present paper is an interim report on the first 316 patients randomized into this trial. The placebo (n = 170) and active treatment (n = 146) groups were similar at randomization with respect to age (73 +/- 8 years; mean +/- SD), sitting blood pressure (178 +/- 12 mm Hg systolic; 85 +/- 7 mm Hg diastolic), percentage of men (34%), and percentage of patients with cardiovascular complications (29%). After randomization blood pressure fell more (p less than 0.001) in patients on active treatment than in those in the placebo group (19 +/- 20 mm Hg systolic; 6 +/- 10 mm Hg diastolic vs. 7 +/- 19 and 1 +/- 10 mm Hg for sitting blood pressure). This first interim report on the Syst-Eur trial demonstrates that a multinational trial in elderly patients with ISH is feasible and that a significant blood pressure difference between the two treatment groups can be achieved and maintained. New centers are being recruited in order to randomize a total of 3,000 patients.
authors.affiliation: Laboratorium Hypertensie, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium.
authors.forename: J
authors.initials: J
authors.lastname: Staessen
authors.forename: A
authors.initials: A
authors.lastname: Amery
authors.forename: W
authors.initials: W
authors.lastname: Birkenhäger
authors.forename: C J
authors.initials: CJ
authors.lastname: Bulpitt
authors.forename: J
authors.initials: J
authors.lastname: Cox
authors.forename: P
authors.initials: P
authors.lastname: de Leeuw
authors.forename: P
authors.initials: P
authors.lastname: De Cort
authors.forename: R
authors.initials: R
authors.lastname: Fagard
authors.forename: A
authors.initials: A
authors.lastname: Fletcher
authors.forename: F
authors.initials: F
authors.lastname: Forette
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000453:epidemiology / Q000517:prevention & control; D004311:Double-Blind Method; D004656:Enalapril / Q000627:therapeutic use; D005060:Europe; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D009568:Nitrendipine / Q000627:therapeutic use; D013599:Systole
chemical_list: D000959:Antihypertensive Agents; D006852:Hydrochlorothiazide; D004656:Enalapril; D009568:Nitrendipine